Dreyling et al. Early consolidation with myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression – free survival in mantle cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood 105: 2677–2684, 2005. http://bloodjournal.hematologylibrary.org/content/105/7/2677
nih.gov
ncbi.nlm.nih.gov
Rummel et al. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20. http://www.ncbi.nlm.nih.gov/pubmed/23433739
